Corpus callosum volume and interhemispheric transfer in multiple sclerosis

Canadian Journal of Neurological Sciences

Volumn 37, Issue 5, 2010, Pages 615-619

  Brown, L N ^a   Zhang, Y ^a   Mitchell, J R ^a   Zabad, R ^b   Metz, L M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORPUS CALLOSUM; FEMALE; HUMAN; INTERHEMISPHERIC TRANSFER; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SENSATION; TACTILE STIMULATION;

EID: 77957574526     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100010787     Document Type: Article

References (27)

1. Lazeron RHC, De Sonneville LMJ, Scheltens P, Polman CH, Barkhof F. Cognitive slowing in multiple sclerosis is strongly associated with brain volume reduction. Mult Scler. 2006;12:760-8.
2. Barkhof F, Elton M, Lindeboom J, Tas MW, Schmidt WF, Hommes OR, et al. Functional correlates of callosal atrophy in relapsingremitting multiple sclerosis patients. A preliminary MRI study. J Neurol. 1998;245:153-8.
3. Barnard RO, Triggs M. Corpus callosum in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1974;37:1259-64.
4. Dietemann JL, Beigelman S, Rumbach L, Vouge M, Tajamady T, Faubert C, et al. Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data. Neuroradol. 1988;30:478-80.
5. Evangelou N, Esiri M, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol. 2000;47:391-5.
6. Figueira F, Santos VS, Figueira G, Silva ACM. Corpus callosum index: a practical method for long-term follow-up in multiple sclerosis. Arq Neuropsiquiatr. 2007;65:931-5.
7. Gean-Marton AD, Vezina LG, Marton KI, Stimac GK, Peyster RG, Taveras JM, et al. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Neuroradiol. 1991;180:215-21.
8. Joonmi OH, Pelletier D, Nelson SJ. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging. Arch Neurol. 2004;61:1081-6.
9. Martola J, Stawiarz L, Fredikson S, Hillert J, Bergström J, Flodmark O, et al. Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development. J Neurol Neurosurg Psychiatry. 2007;78:375-80.
10. Simon JH, Holtäs SL, Schiffer RB, Rudick RA, Herndon RM, Kido DK, et al. Corpus callosum and subcallosal periventricular lesions in multiple sclerosis: Detection with MR Radiol. 1986;160:363-7.
11. Pelletier J, Suchet L, Witjas T, Habib M, Guttmann CRG, Salamon G, et al. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol. 2001;58:105-11.
12. Boroojerdi B, Hungs M, Mull M, Töpper R, Noth J. Interhemispheric inhibition in patients with multiple sclerosis. Electroencephalogr Clin Neurophysiol. 1998;109:230-7.
13. Brown LN, Metz LM, Sainsbury RS. Sensory temporal thresholds and interhemispheric transfer times in multiple sclerosis: a preliminary study of a new outcome measure. J Clin Exp Neuropsych. 2003;25:783-92.
14. Höppner J, Kunesch E, Buchmann J, Hess A, Großmann A, Benecke R. Demyelination and axonal degeneration in corpus callosum assessed by analysis of transcallosally mediated inhibition in multiple sclerosis. Clin Neurophysiol. 1999;110:748-56.
15. Larson EB, Burnison DS, Brown WS. Callosal function in multiple sclerosis: Bimanual motor coordination. Cortex. 2002;38:201-14.
16. Manson SC, Palace J, Frank JA, Matthews PM. Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy. Exp Brain Res. 2006;174:728-33.
17. Pelletier J, Habib M, Lyon-Caen O, Salamon G, Poncet M, Khalil R. Functional and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis. Arch Neurol. 1993;50:1077-82.
18. Rao SM, Bernardin L, Leo GJ, Ellington L, Ryan SB, Burg LS. Cerebral disconnection in multiple sclerosis: relationship to atrophy of the corpus callosum. Arch Neurol. 1989;46:918-20.
19. Schmierer K, Niehaus L, Röricht S, Meyer B-U. Conduction deficits of callosal fibers in early multiple sclerosis. J Neurol Neurosurg Psychiatry. 2000;68:633-8.
20. Schnider A, Benson DF, Rosner LJ. Callosal disconnection in multiple sclerosis. Neurology. 1993;43:1243-5.
21. Warlop NP, Achten E, Debruyne J, Vingerhoets G. Diffusion weighted callosal integrity reflects interhemispheric communication efficiency in multiple sclerosis. Neuropsychologia. 2008;46:2258-64.
22. Wishart HA, Strauss E, Hunter M, Moll A. Interhemispheric transfer in multiple sclerosis. J Clin Exp Neuropsychol. 1995;17:937-40.
23. Brown LN, Metz LM, Eliasziw M. Identifying reliable change in tactile temporal thresholds in multiple sclerosis: test-retest reliability. Mult Scler. 2006;12:573-7.
24. Brown LN, Metz LM. Tactile temporal thresholds measure relapserelated change in multiple sclerosis: a preliminary study. Mult Scler. 2005;11:725-7.
25. McDonald WI, Comptson A, Edan G and the International Panel Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001;50:121-7.
26. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Ann Neurol. 1983;13:227-31.
27. Bowers ME, Trinh N, Tung GA, Crisco JJ, Kimia BB, Fleming BC. Quantitative MR imaging using "LiveWire" to measure tibiofemoral articular cartilage thickness. Osteoarthritis Cartilage. 2008;16(10):1167-73.